TY - JOUR
KW - drug utilization study
KW - liraglutide
KW - obesity therapy
KW - off‐label potential
KW - real‐world use
KW - Type 2 diabetes
AU - T. Murray-Thomas
AU - J. Dcruz
AU - N. Harder-Lauridsen
AU - A. Olsen
AU - R. Williams
AU - A. Major-Pedersen
AD - Clinical Practice Research Datalink, Medicines and Healthcare Products Regulatory Agency, London.
Novo Nordisk A/S, Søborg, Denmark.
Novo Nordisk A/S, Global Patient Safety, Søborg, Denmark.
AN - 40292833
BT - Diabetes Obes Metab
DO - 10.1111/dom.16393
DP - NLM
ET - 2025/04/28
LA - eng
N1 - 1463-1326
Murray-Thomas, Tarita
Dcruz, John M
Harder-Lauridsen, Nina M
Olsen, Anne H
Williams, Rachael
Major-Pedersen, Atheline
Orcid: 0000-0002-1755-630x
Novo Nordisk/
Journal Article
England
Diabetes Obes Metab. 2025 Apr 28. doi: 10.1111/dom.16393.
PY - 2025
SN - 1462-8902
T2 - Diabetes Obes Metab
TI - Real-world use of liraglutide for weight management according to label in the United Kingdom: A cohort study using the Clinical Practice Research Datalink primary care databases
ER -